Related Experiment Video
Updated: Feb 28, 2026

Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock
Published on: June 12, 2021
Integrating Interventional Cardiology and Heart Failure Management for Cardiogenic Shock
Navin K Kapur1, Carlos D Davila1, Marwan F Jumean2
1The Acute Mechanical Support Working Group, The Cardiovascular Center, Tufts Medical Center, 800 Washington Street, Boston, MA 02111, USA.
Insights
Cardiogenic shock, a common cause of in-hospital death, is increasingly complex. Percutaneous acute mechanical circulatory support (AMCS) offers improved outcomes for these high-risk patients.
Area of Science:
- Cardiology
- Interventional Cardiology
- Heart Failure Management
Background:
- Cardiogenic shock is a leading cause of in-hospital mortality.
- Increasing patient complexity, particularly with acute myocardial infarction, complicates cardiogenic shock management.
- Percutaneous acute mechanical circulatory support (AMCS) use has risen significantly over the last decade.
Purpose of the Study:
- To review current guidelines and consensus statements on AMCS for cardiogenic shock.
- To highlight the evolving role of interventional heart failure specialists.
- To emphasize the integration of advanced hemodynamic and catheter-based therapies.
Main Methods:
- Review of recent data and existing literature on cardiogenic shock and AMCS.
- Analysis of emerging guidelines and consensus statements.
- Discussion of the interdisciplinary heart team approach.
Main Results:
- Guidelines are emerging for patient selection, timing, device choice, and post-implantation care for AMCS.
- Interventional heart failure specialists are crucial in managing complex hemodynamic and catheter-based therapies.
- The focus is on improving patient outcomes through integrated care.
Conclusions:
- Optimizing patient selection and management strategies for AMCS is critical.
- The expertise of interventional heart failure specialists is essential for successful AMCS implementation.
- Advanced hemodynamic and catheter-based therapies are key to improving outcomes in cardiogenic shock.
Abstract:
Cardiogenic shock remains one of the most common causes of in-hospital death. Recent data have identified an overall increase in patient complexity, with cardiogenic shock in the setting of acute myocardial infarction. The use of percutaneous acute mechanical circulatory support (AMCS) has steadily grown in the past decade. Guidelines and consensus statements addressing proper patient selection, timing of AMCS implantation, device choice, and postimplantation protocol are appearing. The emerging role of interventional heart failure specialists within the heart team includes integration and understanding of advanced hemodynamic and cathether-based therapies, with the goal of improving outcomes.
Related Concept Videos
Heart Failure VI: Adjunct Therapies
Cardiomyopathy V: Interprofessional Care
Acute Coronary Syndrome IV: Interprofessional Care
Heart Failure V: Medical Management
Cardiomyopathy II: Dilated Cardiomyopathy
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

